Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G H Talbot

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Antimicrobial Chemotherapy|May 1, 2001
Successful administration of quinupristin/dalfopristin in the outpatient settingS J Rehm, D R Graham, L Srinath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1985
Invasive pulmonary aspergillosis in adult acute leukemia: clinical clues to its diagnosisS L Gerson, G H Talbot, E Lusk, et al.
Annals of Internal Medicine|March 1, 1984
Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemiaS L Gerson, G H Talbot, S Hurwitz, et al.
The American Journal of Medicine|July 1, 1985
Discriminant scorecard for diagnosis of invasive pulmonary aspergillosis in patients with acute leukemiaS L Gerson, G H Talbot, S Hurwitz, et al.
The American Journal of Medicine|November 1, 1989
Risk factors for Amphotericin B-associated nephrotoxicityM A Fisher, G H Talbot, G Maislin, et al.
American Journal of Infection Control|August 1, 1984
Enterobacter cloacae-contaminated cardioplegic solution. Discovery and eradication of a pharmacy reservoirG H Talbot, D E Miller, M Doorley, et al.
Radiology|December 1, 1985
Invasive pulmonary aspergillosis and acute leukemia. Limitations in the diagnostic utility of the air crescent signW B Gefter, S M Albelda, G H Talbot, et al.
Chest|July 23, 1998
Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study GroupC A DeAbate, D Henry, G Bensch, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2013
Phase II clinical study of BC-3781, a pleuromutilin antibiotic, in treatment of patients with acute bacterial skin and skin structure infectionsW T Prince, Z Ivezic-Schoenfeld, C Lell, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study GroupD Henry, W Ellison, J Sullivan, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Antimicrobial Chemotherapy|May 1, 2001
Successful administration of quinupristin/dalfopristin in the outpatient settingS J Rehm, D R Graham, L Srinath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1985
Invasive pulmonary aspergillosis in adult acute leukemia: clinical clues to its diagnosisS L Gerson, G H Talbot, E Lusk, et al.
Annals of Internal Medicine|March 1, 1984
Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemiaS L Gerson, G H Talbot, S Hurwitz, et al.
The American Journal of Medicine|July 1, 1985
Discriminant scorecard for diagnosis of invasive pulmonary aspergillosis in patients with acute leukemiaS L Gerson, G H Talbot, S Hurwitz, et al.
The American Journal of Medicine|November 1, 1989
Risk factors for Amphotericin B-associated nephrotoxicityM A Fisher, G H Talbot, G Maislin, et al.
American Journal of Infection Control|August 1, 1984
Enterobacter cloacae-contaminated cardioplegic solution. Discovery and eradication of a pharmacy reservoirG H Talbot, D E Miller, M Doorley, et al.
Radiology|December 1, 1985
Invasive pulmonary aspergillosis and acute leukemia. Limitations in the diagnostic utility of the air crescent signW B Gefter, S M Albelda, G H Talbot, et al.
Chest|July 23, 1998
Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study GroupC A DeAbate, D Henry, G Bensch, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2013
Phase II clinical study of BC-3781, a pleuromutilin antibiotic, in treatment of patients with acute bacterial skin and skin structure infectionsW T Prince, Z Ivezic-Schoenfeld, C Lell, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study GroupD Henry, W Ellison, J Sullivan, et al.
Pageof 8